JOHNSON & JOHNSON 4

EVP Jennifer L. Taubert exercised 15,000 stock options and sold 15,000 shares of Johnson & Johnson common stock on 2026-08-17.

On August 17, 2026, Jennifer L. Taubert, EVP, WWC. Innovative Medicine at Johnson & Johnson, exercised 15,000 employee stock options with a strike price of $115.67 per share, acquiring 15,000 shares of Johnson & Johnson common stock for approximately $1.73 million, and on the same day sold 15,000 shares at a weighted average price of $263.36 per share for proceeds of about $3.95 million. The option exercise derives from an award granted on February 13, 2020 under the issuer’s Long-Term Incentive Plan, which became exercisable on the third anniversary of the grant date. Following these transactions, she reported direct ownership of 194,451.001 shares of Johnson & Johnson common stock, with an indicative market value of roughly $52.7 million based on the current stock price.

Filing Facts

CIK

200406

Ticker

JNJ

Form

4

Source Type

fda

Accession

0000200406-26-000175

Alert Tier

6